Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial - Concepedia

Concepedia

Publication | Open Access

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial

DOI Full Paper Access

168

Citations

26

References

2010

Year

Andrés Poveda, Ignace Vergote, Sergei Tjulandin, Beihua Kong, Moni Roy, Stephen Chan, Emilia Filipczyk−Cisarż, H Hagberg, S.B. Kaye, Nicoletta Colombo,

Annals of Oncology

References

	Year	Citations

Page 1